Diagnostic Histopathology
Volume 15, Issue 8 , Pages 373-381 , August 2009

Fibroepithelial neoplasms of the breast

References 

  1. Dupont WD, Page DL, Parl FF, et al. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med. 1994;331:10–15
  2. Sklair-Levy M, Sella T, Alweiss T, Craciun I, Libson E, Mally B. Incidence and management of complex fibroadenomas. AJR Am J Roentgenol. 2008;190:214–218
  3. Groussin L, Kirschner LS, Vincent-Dejean C, et al. Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD. Am J Hum Genet. 2002;71:1433–1442
  4. Carney JA, Toorkey BC. Myxoid fibroadenoma and allied conditions (myxomatosis) of the breast. A heritable disorder with special associations including cardiac and cutaneous myxomas. Am J Surg Pathol. 1991;15:713–721
  5. Powell CM, Cranor ML, Rosen PP. Multinucleated stromal giant cells in mammary fibroepithelial neoplasms. A study of 11 patients. Arch Pathol Lab Med. 1994;118:912–916
  6. Berean K, Tron VA, Churg A, Clement PB. Mammary fibroadenoma with multinucleated stromal giant cells. Am J Surg Pathol. 1986;10:823–827
  7. Hertel BF, Zaloudek C, Kempson RL. Breast adenomas. Cancer. 1976;37:2891–2905
  8. Pike AM, Oberman HA. Juvenile (cellular) adenofibromas. A clinicopathologic study. Am J Surg Pathol. 1985;9:730–736
  9. Tham K-T, Dupont WD, Page DL, Gray GFJ, Rogers LW. Micropapillary hyperplasia with atypical features in female breasts, resembling gnaecomastia. 10th edn.. New York: Field and Wood; 1989;p. 101–9
  10. Mies C, Rosen PP. Juvenile fibroadenoma with atypical epithelial hyperplasia. Am J Surg Pathol. 1987;11:184–190
  11. Daroca PJ, Reed RJ, Love GL, Kraus SD. Myoid hamartomas of the breast. Hum Pathol. 1985;16:212–219
  12. Fisher CJ, Hanby AM, Robinson L, Millis RR. Mammary hamartomas – a review of 35 cases. Histopathology. 1992;20:99–106
  13. Sawyer EJ, Hanby AM, Ellis P, et al. Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components. Am J Pathol. 2000;156:1093–1098
  14. Sawyer EJ, Hanby AM, Rowan A, et al. The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours. J Pathol. 2002;196:437–444
  15. Sawyer EJ, Hanby AM, Poulsom R, et al. Beta-catenin abnormalities and associated insulin-like growth factor overexpression are important in phyllodes tumours and fibroadenomas of the breast. J Pathol. 2003;200:627–632
  16. Sawyer EJ, Poulsom R, Hunt FT, et al. Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit. J Pathol. 2003;200:59–64
  17. Tse GM, Lui PC, Vong JS, et al. Increased epidermal growth factor receptor (EGFR) expression in malignant mammary phyllodes tumors. Breast Cancer Res Treat. 2009;114:441–448
  18. Lv S, Niu Y, Wei L, Liu Q, Wang X, Chen Y. Chromosomal aberrations and genetic relations in benign, borderline and malignant phyllodes tumors of the breast: a comparative genomic hybridization study. Breast Cancer Res Treat. 2008;112:411–418
  19. Chua CL, Thomas A, Ng BK. Cystosarcoma phyllodes – Asian variations. Aust N Z J Surg. 1988;58:301–305
  20. Lee AH. Recent developments in the histological diagnosis of spindle cell carcinoma, fibromatosis and phyllodes tumour of the breast. Histopathology. 2008;52:45–57
  21. Cohn-Cedermark G, Rutqvist LE, Rosendahl I, Silfversward C. Prognostic factors in cystosarcoma phyllodes. A clinicopathologic study of 77 patients. Cancer. 1991;68:2017–2022
  22. In:  Tavassoli FA,  Devilee P editor. Pathology and genetics of tumours of the breast and female genital tract. Lyon: IARC Press; 2003;
  23. Jones A, Mitter R, Springall R, et al. A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra-tumoral genetic heterogeneity and new genetic changes on recurrence. J Pathol. 2008;214:533–544
  24. Moffat CJ, Pinder SE, Dixon AR, Elston CW, Blamey RW, Ellis IO. Phyllodes tumours of the breast: a clinicopathological review of thirty-two cases. Histopathology. 1995;27:205–218
  25. Millis RR, Hanby AM, Oberman HA. The Breast. In:  Sternberg SS editors. Diagnostic Surgical Pathology, vol. 1. New York: Raven Press; 1999;p. 319–385
  26. Rowell MD, Perry RR, Hsiu JG, Barranco SC. Phyllodes tumors. Am J Surg. 1993;165:376–379
  27. Kefeli M, Yildiz L, Akpolat I, Balci P, Ozen N. The coexistence of invasive ductal carcinoma and malignant phyllodes tumor with liposarcomatous and chondrosarcomatous differentiation in the same breast in a post-osteosarcoma case. Pathol Res Pract. 2008;204:919–923
  28. Norris HJ, Taylor HB. Relationship of histologic features to behavior of cystosarcoma phyllodes. Analysis of ninety-four cases. Cancer. 1967;20:2090–2099
  29. Vera-Sempere F, Garcia-Martinez A. Malignant phyllodes tumor of the breast with predominant chondrosarcomatous differentiation. Pathol Res Pract. 2003;199:841–845
  30. Lee AH, Hodi Z, Ellis IO, Elston CW. Histological features useful in the distinction of phyllodes tumour and fibroadenoma on needle core biopsy of the breast. Histopathology. 2007;51:336–344
  31. Yohe S, Yeh IT. “Missed” diagnoses of phyllodes tumor on breast biopsy: pathologic clues to its recognition. Int J Surg Pathol. 2008;16:137–142
  32. Coyne JD. Periductal stromal hyperplasia. Histopathology. 2007;50:814–815
  33. Burga AM, Tavassoli FA. Periductal stromal tumor: a rare lesion with low-grade sarcomatous behavior. Am J Surg Pathol. 2003;27:343–348

PII: S1756-2317(09)00107-8

doi: 10.1016/j.mpdhp.2009.05.002

Diagnostic Histopathology
Volume 15, Issue 8 , Pages 373-381 , August 2009

Article Tools

* Image Usage & Resolution